Reversible bone marrow dysplasia in patients with systemic lupus erythematosus

Internal Medicine

Volumn 47, Issue 8, 2008, Pages 737-742

  Oka, Yumiko ^a   Kameoka, Junichi ^a   Hirabayashi, Yasuhiko ^a   Takahashi, Reiko ^a   Ishii, Tomonori ^a   Sasaki, Takeshi ^a   Harigae, Hideo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone marrow; Cytopenia; Dysplasia; Myelodysplastic syndrome; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEMOGLOBIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG PULSE THERAPY; ERYTHROBLAST; ERYTHROID CELL; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE DISORDER; LEUKOPENIA; MALE; MEDICAL RECORD REVIEW; MEGAKARYOCYTE; MONOTHERAPY; MULTINUCLEAR CELL; MYELODYSPLASIA; PLASMAPHERESIS; PROLIFERATIVE GLOMERULONEPHRITIS; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; ADOLESCENT; BONE DYSPLASIA; BONE MARROW; CHILD; HOSPITALIZATION; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY;

ADOLESCENT; ADULT; BIOPSY, FINE-NEEDLE; BONE DISEASES, DEVELOPMENTAL; BONE MARROW; CHILD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEGAKARYOCYTES; MEGALOBLASTS; MIDDLE AGED; MYELOID CELLS; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 44649135727     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0607     Document Type: Article

References (18)

1. Clatch RJ, Krigman HR, Peters MG, Zutter MM. Dysplastic haemopoiesis following orthotopic liver transplantation: comparison with similar changes in HIV and primary myelodysplasia. Br J Haematol 88: 685-692, 1994.
2. Yarali N, Duru F, Sipahi T, Kara A, Tezic T. Parvovirus B19 infection reminiscent of myelodysplastic syndrome in three children with chronic hemolytic anemia. Pediatr Hematol Oncol 17: 475-482, 2000.
3. Yetgin S, Çetin M, Yenicesu I, Özaltin I, Uçkan D. Acute parvovirus B19 infection mimicking juvenile myelomonocytic leukemia. Eur J Haematol 65: 276-278, 2000.
4. Yetgin S, Özen S, Saatci Ü, Bakkaloglu. A, Besbas N, Kirel B. Myelodysplastic features in juvenile rheumatoid arthritis. Am J Hematol 54: 166-169, 1997.
5. Feng CS, Ng, MH, Szeto RS, Li EK. Bone marrow findings in lupus patients with pancytopenia. Pathology 23: 5-7, 1991.
6. Voulgarelis M, Gannouli S, Tasidou A, Anagnostou D, Ziakas PD, Tzioufas AG. Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study. Am J Hematol 81: 590-597, 2006.
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725 (letter), 1997.
8. Michael SR, Vural IL, Bassen FA, Schaefer L. The hematologic aspcts of disseminated (systemic) lupus erythematosus. Blood 6: 1059-1072, 1951.
9. Burkhardt R. The bone marrow in systemic lupus erythematosus. Semin Hematol 2: 29-46, 1965.
10. Rosenfeld C, List A. A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. Leukemia 14: 2-8, 2000.
11. Papadaki HA. Autoreactive T-lymphocytes are implicated in the pathogenesis of bone marrow failure in patients with systemic lupus erythematosus. Leuk Lymphoma 44: 1301-1307, 2003.
12. Sun LY, Zhou KX, Fan LM, et al. Abnormal surface markers expression on bone marrow CD34+ cells and correlation with disease activity in patients with systemic lupus erythematosus. Clin Rheumato 26 (12): 2073-2079, 2007.
13. Nagafuji K, Shibuya T, Niho Y, et al. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86 (3): 883-889, 1995.
14. Otsuka T, Okamura S, Niho Y, et al. Multipotent hemopoietic progenitor cells in patients with systemic lupus erythematosus. J Rheumatol 15 (7): 1085-1090, 1988.
15. Bailey FA, Lilly M, Bertoli LF, Ball GV. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia. Arthritis Rheum 32 (7): 901-905, 1989.
16. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 91: 403-408, 1995.
17. Funato K, Kuriyama Y, Uchida Y, Suzuki A, Miyazawa K, Ohyashiki K. Myelodysplastic syndrome accompanied by Addison's disease and multiple autoimmune phenomena: Steroid therapy resolved cytopenias and all immune disorders. Intern Med 40: 1041-1044, 2001.
18. Saif MW, Hopkins JL, Gore SD. Autoinumme phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 43: 2083-2092, 2002.